Clinical trial / 1982
Moderate sodium restriction significantly lowered supine blood pressure in patients with mild to moderate essential hypertension.
Nineteen patients with mild to moderate essential hypertension underwent sodium restriction and were randomized in an 8-week double-blind crossover study comparing Slow Sodium against placebo. In the fourth week of placebo, mean supine blood pressure was 7.1 mm Hg (6.1%) lower than in the fourth week of Slow Sodium (p < 0.001). Urinary sodium excretion was 86 +/- 9 mmol/24 h on placebo compared to 162 +/- 9 mmol/24 h on Slow Sodium (p < 0.001), with no difference observed in potassium excretion.
- Study type
- Double-blind randomised crossover trial
- Who was studied
- 19 unselected patients with mild to moderate essential hypertension
- What was measured
- Supine blood pressure and 24-hour urinary sodium and potassium excretion
THE PAPER
Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension.
MacGregor GA, Markandu ND, Best FE, Elder DM, Cam JM, Sagnella GA, Squires M. Lancet, 1982.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.